2Y-Chem was founded in 2003. 2Y-Chem, Ltd. and 2Y-Biopharma, Ltd. operate as an integrated CDMO, providing pharmaceutical development and cGMP manufacturing services to leading innovative biotech and pharmaceutical companies for regulatory applications in the United States, Europe and China. With more than 20 years of dedicated CMC experience, 2Y-Chem has served more than 200 NME projects worldwide, ranging from preclinical, clinical to commercial stages. 2Y-Chem is a member of Chemexpress Group, a company listed in the SSE.

The wholly owned cGMP drug product manufacturing plant 2Y-Biopharma, Ltd. was established in 2017. In recent years, 2Y-Biopharma has supported 8 MAH clients in achieving the marketing approval of innovative or generic drugs and has been entrusted for commercial production.